Study of Cardiac Fibroblasts Changing to Myofibroblasts
Author Information
Author(s): Nagalingam Raghu Sundaresan, Jayousi Farah, Hamledari Homa, Dababneh Saif, Hosseini Dina, Lindsay Chloe, Klein Geltink Ramon, Lange Philipp F., Dixon Ian Michael, Rose Robert Alan, Czubryt Michael Paul, Tibbits Glen Findlay
Primary Institution: BC Children's Hospital Research Institute
Hypothesis
Can hiPSC-derived cardiac fibroblasts be activated to become myofibroblasts like primary cells?
Conclusion
The study shows that passaging hiPSC-derived cardiac fibroblasts enhances their activation and metabolic changes similar to primary cardiac fibroblasts.
Supporting Evidence
- Passaging promotes the activation of fibroblasts to myofibroblasts.
- TGFβ1 treatment activates the fibroblasts, but their expression profile was uniquely different from passaged myofibroblasts.
- High energy requiring fibroblast activation is dependent on glutaminase-based mitochondrial metabolism.
- Passaging induces TGFβ1 and Hippo signaling pathways in activated fibroblasts and myofibroblasts.
Takeaway
This research found that when certain heart cells are passed through multiple stages, they change and become more active, similar to how they behave in a real heart.
Methodology
The study involved activating hiPSC-derived cardiac fibroblasts through serial passaging and TGFβ1 treatment, followed by transcriptomic, proteomic, and metabolomic profiling.
Limitations
The study used TGFβ1 and passaging to activate fibroblasts, which may not fully represent all activation mechanisms.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website